Skip to content
Home/Companies/MedTech/Palodex

Palodex

MedTech·Finland·Exited 2009·Held 4yr
Entry
2005
Hold
4yr
Exit
2009

Who owns Palodex?

Palodex is a Finnish MedTech company, now owned by Danaher, which acquired it in 2009 from Altor Equity Partners.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Altor Equity Partners
Investor
Altor Equity Partners
Altor Fund I · 2003 · Buyout

Key facts

HQFinland
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
Danaher
Exit Year
2009

More from Altor Fund I

Other portfolio companies in the same fund.

Aalborg Industries
Exited 2011
IndustrialsDenmark· 2005
to Alfa Laval
Byggmax
Exited 2010
ConsumerSweden· 2005
Ferrosan
Exited 2011
ConsumerDenmark· 2005
to Pfizer
Ferrosan Medical Devices
Exited 2016
MedTechDenmark· 2005
to Consortium of Nordic family offices
Meyn
Exited 2012
IndustrialsNetherlands· 2005
to CTB Inc (Berkshire Hathaway)
Relacom
Exited 2012
TelecomSweden· 2005
to Nordea, DNB NOR and HSH Nordbank

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Palodex?

Palodex is now owned by Danaher, which acquired it in 2009 from Altor Equity Partners.

When did Danaher acquire Palodex?

Danaher acquired Palodex in 2009, buying from Altor Equity Partners.

Who did Palodex sell to?

Altor Equity Partners sold Palodex to Danaher in 2009 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue